Dichlorphenamide

This MedLibrary.org supplementary page on Dichlorphenamide is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Diclofenamide
Systematic (IUPAC) name
4,5-dichlorobenzene-1,3-disulfonamide
Identifiers
CAS number 120-97-8
ATC code S01EC02
PubChem 3038
DrugBank APRD00131
Chemical data
Formula C6H6Cl2N2O4S2 
Mol. mass 305.16 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding 55%
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor.

References

  • Tawil R, McDermott M, Brown R, Shapiro B, Ptacek L, McManis P, Dalakas M, Spector S, Mendell J, Hahn A, Griggs R (2000). "Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis.". Ann Neurol 47 (1): 46–53. PMID 10632100. 
  • Okada S, Izumi W, Murai M, Komatsu H, Ishimitsu S (1991). "[Diclofenamide Reference Standard (Control 891) of National Institute of Hygienic Sciences]". Eisei Shikenjo Hokoku 109: 148–50. PMID 1364383. 

Wikipedia content modification information:

  • This page was last modified on 31 May 2008, at 14:47.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Dichlorphenamide".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.